In:
Infection, Springer Science and Business Media LLC, Vol. 49, No. 1 ( 2021-02), p. 181-186
Abstract:
We present four cases with Gram-positive bacteremia (pathogens: MRSA n = 1 , Enterococcus spp. n = 3) due to an intravascular source (left ventricular assist device: n = 2, transfemoral aortic valve implantation n = 1, prosthetic aortic valve: n = 1) where no curative treatment was available. These patients received indefinite, chronic suppressive (palliative) therapy with dalbavancin (500 mg weekly or 1000 mg biweekly regimens). Outcomes and clinical characteristics are described; treatment was effective in suppression of bacteremia in all patients over several months (range: 1 to more than 12 months), we observed no relevant side effects.
Type of Medium:
Online Resource
ISSN:
0300-8126
,
1439-0973
DOI:
10.1007/s15010-020-01526-0
Language:
English
Publisher:
Springer Science and Business Media LLC
Publication Date:
2021
detail.hit.zdb_id:
2006315-5
Permalink